Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
A randomized, open-label, parallel design study in healthy participants to assess the effects of itraconazole and rifampin on the single-dose pharmacokinetics of BMS-986205. Safety and tolerability data to be collected and assessed as well.
Age
18–50
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Body mass index 18.0 to 32.0 kg/m2, inclusive
Must have normal renal function demonstrated by GFR, calculated by Chronic Kidney Disease Epidemiology Collaboration formula
Women must not be of childbearing potential (cannot become pregnant)
You may not be if
Any significant acute or chronic medical illness
History of glucose-6-phosphodiesterase (G6PD) deficiency
Personal or family history of cytochrome b5 reductase deficiency
